American Research & Management Company’s Stryker SYK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $2.33M | Sell |
11,512
-183
| -2% | -$38.5K | 0.64% | 48 |
|
|
2022
Q2 | $2.33M | Sell |
11,695
-530
| -4% | -$124K | 0.6% | 50 |
|
|
2022
Q1 | $3.27M | Sell |
12,225
-285
| -2% | -$73.8K | 0.72% | 42 |
|
|
2021
Q4 | $3.35M | Sell |
12,510
-445
| -3% | -$117K | 0.72% | 42 |
|
|
2021
Q3 | $3.42M | Sell |
12,955
-25
| -0.2% | -$6.68K | 0.79% | 39 |
|
|
2021
Q2 | $3.37M | Sell |
12,980
-1,380
| -10% | -$353K | 0.77% | 39 |
|
|
2021
Q1 | $3.5M | Sell |
14,360
-855
| -6% | -$205K | 0.84% | 36 |
|
|
2020
Q4 | $3.73M | Sell |
15,215
-270
| -2% | -$61.2K | 0.97% | 32 |
|
|
2020
Q3 | $3.23M | Sell |
15,485
-470
| -3% | -$91.4K | 0.94% | 32 |
|
|
2020
Q2 | $2.88M | Sell |
15,955
-650
| -4% | -$120K | 0.87% | 34 |
|
|
2020
Q1 | $2.77M | Sell |
16,605
-200
| -1% | -$39.1K | 1.05% | 30 |
|
|
2019
Q4 | $3.53M | Sell |
16,805
-375
| -2% | -$77.8K | 1.04% | 31 |
|
|
2019
Q3 | $3.72M | Sell |
17,180
-200
| -1% | -$42.9K | 1.12% | 28 |
|
|
2019
Q2 | $3.57M | Sell |
17,380
-365
| -2% | -$69.7K | 1.07% | 29 |
|
|
2019
Q1 | $3.5M | Buy |
17,745
+185
| +1% | +$33.3K | 1% | 32 |
|
|
2018
Q4 | $2.75M | Sell |
17,560
-430
| -2% | -$71.9K | 0.93% | 33 |
|
|
2018
Q3 | $3.2M | Sell |
17,990
-235
| -1% | -$40.1K | 0.95% | 31 |
|
|
2018
Q2 | $3.08M | Sell |
18,225
-2,800
| -13% | -$471K | 1.07% | 28 |
|
|
2018
Q1 | $3.38M | Sell |
21,025
-810
| -4% | -$131K | 1.11% | 27 |
|
|
2017
Q4 | $3.38M | Sell |
21,835
-610
| -3% | -$93.1K | 1.04% | 31 |
|
|
2017
Q3 | $3.19M | Sell |
22,445
-290
| -1% | -$41.6K | 1.03% | 30 |
|
|
2017
Q2 | $3.15M | Sell |
22,735
-195
| -0.9% | -$26.8K | 1.04% | 30 |
|
|
2017
Q1 | $3.02M | Sell |
22,930
-440
| -2% | -$55.6K | 1.07% | 29 |
|
|
2016
Q4 | $2.8M | Sell |
23,370
-605
| -3% | -$69.6K | 0.96% | 32 |
|
|
2016
Q3 | $2.79M | Sell |
23,975
-470
| -2% | -$54.8K | 1.02% | 31 |
|
|
2016
Q2 | $2.93M | Sell |
24,445
-739
| -3% | -$82.6K | 1.13% | 31 |
|
|
2016
Q1 | $2.7M | Sell |
25,184
-800
| -3% | -$78.9K | 1.13% | 30 |
|
|
2015
Q4 | $2.42M | Sell |
25,984
-1,418
| -5% | -$136K | 1.03% | 31 |
|
|
2015
Q3 | $2.58M | Sell |
27,402
-700
| -2% | -$69.3K | 1.13% | 29 |
|
|
2015
Q2 | $2.69M | Sell |
28,102
-338
| -1% | -$32K | 1.09% | 30 |
|
|
2015
Q1 | $2.62M | Sell |
28,440
-775
| -3% | -$72.1K | 1.07% | 31 |
|
|
2014
Q4 | $2.76M | Hold |
29,215
| – | – | 1.02% | 34 |
|
|
2014
Q3 | $2.36M | Hold |
29,215
| – | – | 0.85% | 40 |
|
|
2014
Q2 | $2.46M | Sell |
29,215
-300
| -1% | -$24.5K | 0.86% | 38 |
|
|
2014
Q1 | $2.4M | Sell |
29,515
-200
| -0.7% | -$15.9K | 0.86% | 39 |
|
|
2013
Q4 | $2.23M | Buy |
29,715
+50
| +0.2% | +$3.65K | 0.8% | 44 |
|
|
2013
Q3 | $2M | Sell |
29,665
-50
| -0.2% | -$3.45K | 0.79% | 41 |
|
|
2013
Q2 | $1.92M | Buy |
+29,715
| New | +$1.97M | 0.77% | 38 |
|
Other funds holding SYK
GT
American Research & Management Company's SYK Position: Q3 2022 in Review
American Research & Management Company reduced its Stryker (SYK) stake by 1.6% in Q3 2022, selling an estimated $38.5K and leaving 11,512 shares worth $2.33M. The position accounts for 0.64% of the portfolio, ranked #48.
American Research & Management Company first reported a position in SYK in Q2 2013 and has held it in 38 quarters since. The position peaked at $3.73M in Q4 2020. 1,532 funds tracked by Wall St. Rank hold SYK as of Q3 2022.
- American Research & Management Company held 11,512 shares of Stryker worth $2.33M as of Q3 2022.
- American Research & Management Company sold 183 Stryker shares in Q3 2022, an estimated $38.5K.
- Stryker made up 0.64% of American Research & Management Company's portfolio in Q3 2022, its #48 holding.
- American Research & Management Company first reported a position in Stryker in Q2 2013 and has held it in 38 quarters since.
- American Research & Management Company's Stryker position peaked at $3.73M in Q4 2020.
- 1,532 funds tracked by Wall St. Rank held Stryker as of Q3 2022.
Based on American Research & Management Company's 13F filing for Q3 2022, filed 7 Oct 2022.